These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16983952)

  • 21. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular problems in dialysis patients: impact on survival.
    Sidhu MS; Dellsperger KC
    Adv Perit Dial; 2010; 26():47-52. PubMed ID: 21348379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of endothelial dysfunction in chronic kidney disease.
    Malyszko J
    Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between blood pressure and mortality in ESRD-not different from the general population?
    Lacson E; Lazarus JM
    Semin Dial; 2007; 20(6):510-7. PubMed ID: 17991196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6 Suppl 3():S4-12. PubMed ID: 16340933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontiers in nephrology: early atherosclerosis--a view beyond the lumen.
    Gossl M; Lerman LO; Lerman A
    J Am Soc Nephrol; 2007 Nov; 18(11):2836-42. PubMed ID: 17928505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a reversal of reverse epidemiology in renal transplant recipients?
    Chavalitdhamrong D; Danovitch GM; Bunnapradist S
    Semin Dial; 2007; 20(6):544-8. PubMed ID: 17991202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockade in chronic dialysis patients.
    Furgeson SB; Chonchol M
    Semin Dial; 2008; 21(1):43-8. PubMed ID: 18251957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients.
    Lu Q; Cheng LT; Wang T; Wan J; Liao LL; Zeng J; Qin C; Li KJ
    J Ren Nutr; 2008 Nov; 18(6):495-502. PubMed ID: 18940652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target.
    Marson BP; Poli de Figueiredo CE; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):409-15. PubMed ID: 22313633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Kessler M; Zannad F; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P;
    Nephrol Dial Transplant; 2007 Dec; 22(12):3573-9. PubMed ID: 17611249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease.
    Apostolov EO; Basnakian AG; Ok E; Shah SV
    J Ren Nutr; 2012 Jan; 22(1):134-8. PubMed ID: 22200430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Obesity--the risk factor of cardiovascular disease in patients with chronic kidney disease?].
    Lizicárová D; Hirnerová E; Krahulec B
    Vnitr Lek; 2010 Oct; 56(10):1088-92. PubMed ID: 21105458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis hyperhemolysis. A novel mechanism of endothelial dysfunction and cardiovascular risk?
    Donadee CL; Gladwin MT
    J Am Coll Cardiol; 2010 Feb; 55(5):460-2. PubMed ID: 20117460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.